Pharmacin International

Pharmacin is a Netherlands-based pharmaceutical company specializing in the development, registration, and licensing of generic and value-added medicinal products. The company focuses on niche and complex generics, managing the entire product lifecycle from initial formulation and bioequivalence studies to the creation of high-quality regulatory dossiers. Pharmacin operates primarily through a B2B model, licensing its intellectual property and dossiers to international pharmaceutical partners for local commercialization. In 2019, the company was acquired by B&S Group, integrating its development expertise into the group's extensive global distribution network. Its portfolio includes a variety of therapeutic areas, with a notable emphasis on pain management and specialized hospital products.